70.81
Precedente Chiudi:
$72.66
Aprire:
$71.92
Volume 24 ore:
1.12M
Relative Volume:
0.91
Capitalizzazione di mercato:
$12.25B
Reddito:
$8.31B
Utile/perdita netta:
$379.00M
Rapporto P/E:
32.78
EPS:
2.16
Flusso di cassa netto:
$385.00M
1 W Prestazione:
-4.45%
1M Prestazione:
+7.45%
6M Prestazione:
+0.00%
1 anno Prestazione:
+18.15%
Solventum Corp Stock (SOLV) Company Profile
Nome
Solventum Corp
Settore
Industria
Telefono
651-733-1110
Indirizzo
C/O 3M COMPANY, ST. PAUL
Confronta SOLV con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SOLV
Solventum Corp
|
70.81 | 12.82B | 8.31B | 379.00M | 385.00M | 2.16 |
![]()
ISRG
Intuitive Surgical Inc
|
539.54 | 202.00B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
171.38 | 50.27B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
86.52 | 44.43B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
242.84 | 36.90B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
COO
The Cooper Companies, Inc.
|
78.83 | 16.58B | 3.93B | 415.40M | 384.70M | 2.06 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-19 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2024-12-04 | Iniziato | Mizuho | Neutral |
2024-10-08 | Iniziato | Stifel | Buy |
2024-10-07 | Iniziato | Piper Sandler | Neutral |
2024-09-26 | Iniziato | Wolfe Research | Peer Perform |
2024-09-05 | Iniziato | BTIG Research | Neutral |
2024-06-24 | Iniziato | Argus | Hold |
2024-05-30 | Iniziato | Goldman | Sell |
2024-05-10 | Iniziato | BofA Securities | Neutral |
2024-04-10 | Iniziato | Morgan Stanley | Equal-Weight |
2024-04-08 | Iniziato | Wells Fargo | Equal Weight |
2024-04-02 | Iniziato | Edward Jones | Hold |
Mostra tutto
Solventum Corp Borsa (SOLV) Ultime notizie
Ensemble and Solventum to launch autonomous coding solution for hospitals - Yahoo Finance
Piper Sandler Upgrades Solventum (BIT:1SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (LSE:0AD1) - Nasdaq
Ensemble and Solventum Partner to Advance Autonomous Inpatient Coding with AI - The Manila Times
Piper Sandler Upgrades Solventum (BMV:SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (SOLV) - Nasdaq
Assessing Solventum: Insights From 9 Financial Analysts - Benzinga
Piper Sandler raises Solventum stock to Overweight, target to $87 By Investing.com - Investing.com Nigeria
Piper Sandler raises Solventum stock to Overweight, target to $87 - Investing.com
Piper Sandler Upgrades Solventum to Overweight From Neutral, Adjusts Price Target to $87 From $78 - marketscreener.com
Solventum upgraded to Overweight from Neutral at Piper Sandler - TipRanks
Promising Growth and Strategic Flexibility: A Buy Recommendation for Solventum Corporation - TipRanks
After spinoff, 3M is no longer one of Minnesota’s five largest public companies - MSN
Solventum Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Solventum's (NYSE:SOLV) Shareholders Have More To Worry About Than Only Soft Earnings - simplywall.st
Solventum's (NYSE:SOLV) Problems Go Beyond Weak Profit - Yahoo Finance
Solventum Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Solventum Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
People moves: Linda Pazin joins Solventum and Mitch Haws moves to Semtech - IR Impact
Solventum To Present At BofA Securities Health Care Conference; Webcast At 5:20 PM ET - Nasdaq
Solventum sells purification business for $4.1B to pay down debt - MSN
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
Solventum’s projected $100M tariff hit prevents earnings increase - MedTech Dive
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline - MSN
Solventum, facing tariffs of up to $100 million, raises sales guidance - MSN
Solventum Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight - GuruFocus
Solventum beats first-quarter profit estimates on strong surgical product sales - MSN
Solventum (SOLV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
Solventum beats The Street in Q1 and ups revenue guidance - MassDevice
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Solventum Corporation: Cheap, With Caveats (NYSE:SOLV) - Seeking Alpha
Health care manufacturer Solventum faces $100 million tariff hit despite strong Q1 - The Business Journals
Solventum price target lowered to $78 from $80 at Piper Sandler - TipRanks
Solventum Q1 FY25 presentation: raises organic sales outlook despite tariff headwinds - Investing.com
Solventum: Q1 Earnings Snapshot - New Haven Register
Solventum Corp (SOLV) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges - Investing.com Canada
Solventum sees FY25 adjusted EPS $5.45-$5.65, consensus $5.54 - TipRanks
Earnings call transcript: Solventum’s Q1 2025 results show mixed performance - Investing.com
Solventum reports Q1 adjusted EPS $1.34, consensus $1.22 - TipRanks
Solventum Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Solventum Corp Azioni (SOLV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):